Description

7-Methoxy-4,5-Dihydro-1H-Benzo-[G]Indazole-3-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate of significant interest in modern organic synthesis. This compound serves as a critical building block for the development of novel active pharmaceutical ingredients (APIs), particularly those targeting complex therapeutic pathways. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the synthesis of innovative drug candidates, where its specific heterocyclic structure provides a key scaffold for medicinal chemistry.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Active Pharmaceutical Ingredient (API) Development: Employed in the synthesis of complex molecules intended for clinical trial material and eventual commercial API production.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical companies with custom synthesis and process development.
• Academic Research: Utilized in university and institutional labs for studying novel heterocyclic reactions and synthesizing biologically active compounds.

Basic Information

Product Name	7-Methoxy-4,5-Dihydro-1H-Benzo-[G]Indazole-3-Carboxylic Acid
CAS No.	696645-93-9
Molecular Formula	C14H14N2O3
Molecular Weight	258.27 g/mol
Synonyms	7-Methoxy-4,5-dihydro-1H-benzo[g]indazole-3-carboxylic acid; 1H-Benzo[g]indazole-3-carboxylic acid, 4,5-dihydro-7-methoxy-; 696645-93-9; 7-Methoxy-4,5-dihydrobenzo[g]indazole-3-carboxylic acid; Benzo[g]indazole-3-carboxylic acid, 4,5-dihydro-7-methoxy-; 7-Methoxy-4,5-dihydro-1H-benzo[g]indazol-3-carboxylic acid
EINECS	Contact for details

Quality Control

Our 7-Methoxy-4,5-Dihydro-1H-Benzo-[G]Indazole-3-Carboxylic Acid is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support compliance with cGMP and ICH Q7 guidelines for pharmaceutical intermediates, and specifications can be aligned with client-specific requirements for advanced research and development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.